Results 131 to 140 of about 27,759 (158)

Molecular mechanisms and therapies for tumor inhibition through the arginine metabolism pathway. [PDF]

open access: yesFront Oncol
Xu Y   +9 more
europepmc   +1 more source

Cloning, Expression, Purification, Crystallization and Preliminary X-Ray Studies of Argininosuccinate Lyase (Rv1659) From Mycobacterium tuberculosis [PDF]

open access: yesActa Crystallographica Section F: Structural Biology Communications, 2013
The last enzyme in the arginine-biosynthesis pathway, argininosuccinate lyase, from Mycobacterium tuberculosis has been cloned, expressed, purified and crystallized, and preliminary X-ray studies have been carried out on the crystals.
A Surolia
exaly   +3 more sources

Mutations and Polymorphisms in the Human Argininosuccinate Lyase (ASL) Gene [PDF]

open access: yesHuman Mutation, 2014
Argininosuccinate lyase deficiency (ASLD) is caused by a defect of the urea cycle enzyme argininosuccinate lyase (ASL) encoded by the ASL gene. Patients often present early after birth with hyperammonemia but can also manifest outside the neonatal period
Lee-Jun C Wong   +2 more
exaly   +3 more sources

Home - About - Disclaimer - Privacy